Targeting metabolic dysregulation of T cells in kidney cancer

被引：0
|
作者：
Beckermann, Katy
Young, Kirsten
Hongo, Rachel
Ye, Xiang
Contreras, Diana
Barone, Sierra
Roe, Caroline E.
Smith, Christof C.
Vincent, Benjamin Garrett
Irish, Jonathan M.
Rathmell, Wendy Kimryn
Rathmell, Jeffrey C.
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[3] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[4] Vanderbilt Univ, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
722
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting the metabolic basis of kidney cancer
    Linehan, W. Marston
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [2] Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer
    Wang, Gang
    Wang, Jun-Jie
    Guan, Rui
    Sun, Yan
    Shi, Feng
    Gao, Jing
    Fu, Xing-Li
    CURRENT CANCER DRUG TARGETS, 2019, 19 (07) : 534 - 550
  • [3] Targeting metabolic dysregulation for fibrosis therapy
    Zhao, Xiao
    Kwan, Jennifer Yin Yee
    Yip, Kenneth
    Liu, Peter P.
    Liu, Fei-Fei
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (01) : 57 - 75
  • [4] Targeting metabolic dysregulation for fibrosis therapy
    Xiao Zhao
    Jennifer Yin Yee Kwan
    Kenneth Yip
    Peter P. Liu
    Fei-Fei Liu
    Nature Reviews Drug Discovery, 2020, 19 : 57 - 75
  • [5] Metabolic Targeting of Cancer Stem Cells
    Mukha, Anna
    Dubrovska, Anna
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
    Viel, Sebastien
    Vivier, Eric
    Walzer, Thierry
    Marcais, Antoine
    NATURE REVIEWS DRUG DISCOVERY, 2024,
  • [7] Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
    Viel, Sebastien
    Vivier, Eric
    Walzer, Thierry
    Marcais, Antoine
    NATURE REVIEWS DRUG DISCOVERY, 2025, 24 (03) : 190 - 208
  • [8] Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
    Sébastien Viel
    Eric Vivier
    Thierry Walzer
    Antoine Marçais
    Nature Reviews Drug Discovery, 2025, 24 (3) : 190 - 208
  • [9] Metabolic Dysregulation as a Driving Force for Epigenetic Reprogramming in Cancer Cells
    Cyr, Anthony R.
    Madsen, Joshua M.
    Domann, Frederick E.
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 : S168 - S168
  • [10] Targeting MET Dysregulation in Cancer
    Recondo, Gonzalo
    Che, Jianwei
    Janne, Pasi A.
    Awad, Mark M.
    CANCER DISCOVERY, 2020, 10 (07) : 922 - 934
12345